Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients
- PMID: 11725816
- DOI: 10.1007/s007020170003
Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients
Abstract
Antioxidant profiles in Parkinson's disease (PD; n = 15), dementias of Alzheimer's type (DAT; 18) and Vascular (VD; 15), and control subjects (C; 14) were studied. Cu-Zn superoxide dismutase (SOD), catalase (CAT), glutathione system (GLU) and thiobarbituric acid reactive substances (TBARS) were measured in erythrocytes; antioxidant capacity (TRAP) in plasma. Biochemical variables were analyzed simultaneously using multi-variate and non-parametric methods. Clinical diagnostic resulted associated with the main source of variability in antioxidant variables (Kruskal-Wallis: H = 32.58, p = 0.000001). Comparison of PD and C resulted highly significant (z = 4.47, p = 0.000047), demonstrating an association between oxidative stress and PD. SOD and TBARS were significantly higher in pathological groups against C (p = 0.0000001, p = 0.051); TRAP resulted lower (p = 0.00015). Discriminant functions constructed using biochemical variables separated pathological groups (93% success) from C, and DAT (88.9%) from VD (73.3%); but not PD from DAT or VD. Antioxidant profiles of PD patients showed characteristics overlapping with DAT (60%) and with VD (40%), suggesting biochemical similarities between them.
Similar articles
-
Oxidative stress in Alzheimer's and vascular dementias: masking of the antioxidant profiles by a concomitant Type II diabetes mellitus condition.J Neurol Sci. 2004 Mar 15;218(1-2):17-24. doi: 10.1016/j.jns.2003.10.004. J Neurol Sci. 2004. PMID: 14759628
-
The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls.J Neurol Sci. 1996 Sep 15;141(1-2):69-78. doi: 10.1016/0022-510x(96)00163-3. J Neurol Sci. 1996. PMID: 8880696
-
Systemic oxidative stress associated with the neurological diseases of aging.Neurochem Res. 2009 Dec;34(12):2122-32. doi: 10.1007/s11064-009-9997-5. Neurochem Res. 2009. PMID: 19488852
-
[Oxidative stress in the neurodegenerative diseases--potential antioxidant activity of catecholamines].Postepy Biochem. 2010;56(3):248-59. Postepy Biochem. 2010. PMID: 21117312 Review. Polish.
-
Can we prevent Parkinson's and Alzheimer's disease?J Postgrad Med. 2003 Jul-Sep;49(3):236-45. J Postgrad Med. 2003. PMID: 14597787 Review.
Cited by
-
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.Front Pharmacol. 2016 Sep 28;7:343. doi: 10.3389/fphar.2016.00343. eCollection 2016. Front Pharmacol. 2016. PMID: 27733830 Free PMC article.
-
Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism.Neuropsychiatr Dis Treat. 2008 Aug;4(4):715-22. doi: 10.2147/ndt.s3268. Neuropsychiatr Dis Treat. 2008. PMID: 19043515 Free PMC article.
-
Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer's disease.Neurotox Res. 2008 May-Jun;13(3-4):173-84. doi: 10.1007/BF03033501. Neurotox Res. 2008. PMID: 18522897 Review.
-
Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism.FASEB J. 2009 Aug;23(8):2374-83. doi: 10.1096/fj.08-128926. Epub 2009 Mar 23. FASEB J. 2009. PMID: 19307255 Free PMC article.
-
Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2.Br J Clin Pharmacol. 2014 Sep;78(3):441-53. doi: 10.1111/bcp.12357. Br J Clin Pharmacol. 2014. PMID: 25279404 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous